# A stool test for colorectal cancer reaches Brazil's public health system with 400,000 kits

Starting in December, Brazil's Unified Health System (SUS) will offer FIT, a test that looks for invisible blood in stool, to screen for bowel cancer. The target group adds up to 51 million Brazilians aged 50 to 75, but the first batch will hold 400,000 tests.

- Section: Health
- Published: November 19, 2026
- Address: https://ceoone.com.br/en/article/a-stool-test-for-colorectal-cancer-reaches-brazils-public-health-system
- Em português: https://ceoone.com.br/artigo/exame-de-fezes-contra-o-cancer-colorretal-chega-ao-sus-com-400-mil-kits.md

![An opened faecal immunochemical test collection tube on a dark grey fabric, with the mint-green cap attached to a thin rod with a ridged tip lying next to the clear vial with a white label](https://pub-b80e49b2737940b3ab5d3f20d0578192.r2.dev/artigos/exame-de-fezes-contra-o-cancer-colorretal-chega-ao-sus-com-400-mil-kits-foto.webp)

Photo: Whispyhistory (CC BY-SA 4.0)

## Key points

- Brazil's public health system will start offering FIT, a test that looks for hidden blood in stool, to screen for bowel cancer in December.
- The target group is 51 million people aged 50 to 75, but only 400,000 tests will be delivered right away, in state capitals and cities with more than 500,000 inhabitants.
- Colorectal cancer is the second deadliest cancer in Brazil: 27,000 Brazilians died of it last year.

Brazil's Unified Health System (SUS) will begin offering a screening test for bowel cancer in December. Distribution by the Ministry of Health comes seven months after the ministry announced the screening and early diagnosis initiative for this tumour, one of the most common in the country and one that has been rising among younger people.

It is the first colorectal cancer screening initiative to be implemented in Brazil's public health system. The Ministry of Health and the National Cancer Institute (Inca) had been pressed by medical and scientific societies to offer a protocol of this kind, especially given the rise in cases of the disease.

## A simple test instead of the more invasive one

The test chosen is the faecal immunochemical test, known as FIT, which looks for hidden blood in stool. These are small amounts, invisible to the naked eye, that can be a sign of polyps, precancerous lesions or cancer in the bowel.

Colonoscopy remains the best method for diagnosing polyps and other lesions that precede colorectal cancer. FIT was chosen because it is less invasive, requires no bowel preparation or dietary restrictions and has an accuracy rate of between 85% and 92%.

## From the invitation at the clinic to collection at home

Starting in December, teams at Basic Health Units (UBS), the public primary care clinics, are to identify people in the target group and invite them for an appointment. The patient then receives a container to collect a stool sample, which can be done at home or at the clinic itself.

![A bowel cancer home test kit from Australia's national screening programme laid out on a marble surface: instruction leaflets, a return envelope and two collection tubes with green caps](https://pub-b80e49b2737940b3ab5d3f20d0578192.r2.dev/artigos/exame-de-fezes-contra-o-cancer-colorretal-chega-ao-sus-com-400-mil-kits-kit.webp)

Home stool collection kit from Australia's bowel cancer screening programme (illustrative image, not the SUS kit). Photo: Kgbo (CC BY-SA 4.0)

If the result is positive, the patient is referred for a colonoscopy. Positive does not mean cancer: the result calls for a more thorough investigation, which confirms or rules out the disease. A negative result, in turn, does not mean the person is free of all risk, and the ministry recommends repeating the test every two years.

Colonoscopy in people who need it makes it possible to remove polyps before they turn malignant, a process that can take more than ten years. The strategy targets people without symptoms, to reach an early diagnosis or remove polyps that could become cancer years later.

![A gastroenterologist in a surgical cap and mask holds the control dials of an endoscope during a colonoscopy, with the image of the inside of the bowel on a monitor behind him](https://pub-b80e49b2737940b3ab5d3f20d0578192.r2.dev/artigos/exame-de-fezes-contra-o-cancer-colorretal-chega-ao-sus-com-400-mil-kits-colonoscopia.webp)

A colonoscopy at a hospital in Chitré, Panama: the exam that confirms or rules out the disease after a positive FIT (illustrative image). Photo: Andrea Jenkins/U.S. Air Force (public domain)

## People with symptoms should not wait for the invitation

Screening is for people who feel nothing. Anyone who already has a suspicious sign, such as blood in the stool, abdominal pain, weight loss for no apparent reason or a change in bowel habits (diarrhoea or constipation), should see a doctor to assess whether a colonoscopy is needed.

## A small first batch

The ministry set the target group as Brazilians aged 50 to 75, a population of 51 million people, according to the Brazilian Institute of Geography and Statistics (IBGE). Only 400,000 tests, however, will be delivered right away. The figure was given to Estadão's Pulsa section by Flavia Kelli Alvarenga Pinto, deputy director of the ministry's Department of Cancer Care, during the congress of the Brazilian Society of Clinical Oncology (SBOC) on November 7.

"We talked to the states and made a technical suggestion for screening to be implemented in some areas that have the capacity for colonoscopy, because there is no point adopting it in a place that won't be able to follow up with the patient," she said. "We made that recommendation, but each state has the autonomy to choose another place to send the kits to, because it is a small initial quantity."

According to the ministry, the rollout starts in state capitals and in cities with more than 500,000 inhabitants, where it is easier to refer patients who test positive on FIT for colonoscopy and biopsy. "The choice of the municipalities that will start the offer takes into account epidemiological criteria, the availability of colonoscopies and the network's capacity to guarantee diagnosis and treatment for patients," the ministry said.

## The second deadliest cancer in the country

Colorectal cancer is the second deadliest tumour in Brazil, behind only lung cancer. Last year, 27,000 Brazilians died of the disease.

Doctors point out that genetics accounts for only a fraction of diagnoses among younger people, around 20%. Lifestyle factors weigh heavily and are among the reasons for the rise in diagnoses of bowel cancer and other tumours in adults under 50.

## Sources and editorial notes

- Based on the report "Teste para rastrear câncer de intestino estará no SUS em dezembro" (Test to screen for bowel cancer will be in the SUS in December), by Fabiana Cambricoli, published in the Pulsa section (Medicina e Estudos) of the Metrópole section, page A21, of O Estado de S. Paulo on November 19, 2026.

CEO ONE · https://ceoone.com.br

